A Phase 1 Study to Investigate the Food Effect of Lumacaftor in Combination With Ivacaftor

Clinical trial NCT01899105 · COMPLETED

Trial details

NCT number: NCT01899105
Sponsor: Vertex Pharmaceuticals Incorporated
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Cystic Fibrosis

Start date: 2013-07-01
Primary completion: 2013-08-01
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.